{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:49:49Z","timestamp":1794210589986,"version":"4.8.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shire"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1060-2","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T14:13:16Z","timestamp":1556547196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers"],"prefix":"10.1186","volume":"14","author":[{"given":"Magdalena","family":"Harrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Twiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Rushton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"key":"1060_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1651-2227.2008.00648.x","volume":"97","author":"V Gieselmann","year":"2008","unstructured":"Gieselmann V. Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options. Acta Paediatr. 2008;97:15\u201321.","journal-title":"Acta Paediatr"},{"key":"1060_CR2","volume-title":"Scriver's online metabolic and molecular bases of inherited disease","author":"V Gieselmann","year":"2018","unstructured":"Gieselmann V, Kr\u00e4geloh-Mann I. Metachromatic Leukodystrophy. In: Valle D, et al., editors. Scriver's online metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2018."},{"key":"1060_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1469-8749.2011.04028.x","volume":"53","author":"C Kehrer","year":"2011","unstructured":"Kehrer C, Blumenstock G, Gieselmann V, Krageloh-Mann I, German L. The natural course of gross motor deterioration in metachromatic leukodystrophy. Dev Med Child Neurol. 2011;53:850\u20135.","journal-title":"Dev Med Child Neurol"},{"key":"1060_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1172-9-18","volume":"9","author":"C Kehrer","year":"2014","unstructured":"Kehrer C, Groeschel S, Kustermann-Kuhn B, Burger F, Kohler W, Kohlschutter A, et al. Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort. Orphanet J Rare Dis. 2014;9:18.","journal-title":"Orphanet J Rare Dis"},{"key":"1060_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.beem.2014.10.001","volume":"29","author":"DF Rappard van","year":"2015","unstructured":"van Rappard DF, Boelens JJ, Wolf NI. Metachromatic leukodystrophy: disease spectrum and approaches for treatment. Best Pract Res Clin Endocrinol Metab. 2015;29:261\u201373.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1060_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0030-1253412","volume":"41","author":"V Gieselmann","year":"2010","unstructured":"Gieselmann V, Krageloh-Mann I. Metachromatic leukodystrophy--an update. Neuropediatrics. 2010;41:1\u20136.","journal-title":"Neuropediatrics."},{"key":"1060_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1212\/01.wnl.0000234129.97727.4d","volume":"67","author":"H Rauschka","year":"2006","unstructured":"Rauschka H, Colsch B, Baumann N, Wevers R, Schmidbauer M, Krammer M, et al. Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology. 2006;67:859\u201363.","journal-title":"Neurology."},{"key":"1060_CR8","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1177\/0883073816656401","volume":"31","author":"FS Eichler","year":"2016","unstructured":"Eichler FS, Cox TM, Crombez E, Dali CI, Kohlschutter A. Metachromatic Leukodystrophy: an assessment of disease burden. J Child Neurol. 2016;31:1457\u201363.","journal-title":"J Child Neurol"},{"key":"1060_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ajmg.1320330104","volume":"33","author":"JT Clarke","year":"1989","unstructured":"Clarke JT, Skomorowski MA, Chang PL. Marked clinical difference between two sibs affected with juvenile metachromatic leukodystrophy. Am J Med Genet. 1989;33:10\u20133.","journal-title":"Am J Med Genet"},{"key":"1060_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1056\/NEJM199101033240104","volume":"324","author":"A Polten","year":"1991","unstructured":"Polten A, Fluharty AL, Fluharty CB, Kappler J, von Figura K, Gieselmann V. Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med. 1991;324:18\u201322.","journal-title":"N Engl J Med"},{"key":"1060_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbmt.2013.01.010","volume":"19","author":"HR Martin","year":"2013","unstructured":"Martin HR, Poe MD, Provenzale JM, Kurtzberg J, Mendizabal A, Escolar ML. Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. Biol Blood Marrow Transplant. 2013;19:616\u201324.","journal-title":"Biol Blood Marrow Transplant."},{"key":"1060_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13023-015-0313-y","volume":"10","author":"AA Boucher","year":"2015","unstructured":"Boucher AA, Miller W, Shanley R, Ziegler R, Lund T, Raymond G, et al. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report. Orphanet J Rare Dis. 2015;10:94.","journal-title":"Orphanet J Rare Dis."},{"key":"1060_CR13","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1182\/blood-2016-03-708479","volume":"127","author":"DF Rappard van","year":"2016","unstructured":"van Rappard DF, Boelens JJ, van Egmond ME, Kuball J, van Hasselt PM, Oostrom KJ, et al. Efficacy of hematopoietic cell transplantation in metachromatic leukodystrophy: the Dutch experience. Blood. 2016;127:3098\u2013101.","journal-title":"Blood."},{"key":"1060_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/jamaneurol.2016.2067","volume":"73","author":"S Groeschel","year":"2016","unstructured":"Groeschel S, Kuhl JS, Bley AE, Kehrer C, Weschke B, Doring M, et al. Long-term outcome of allogeneic hematopoietic stem cell transplantation in patients with juvenile metachromatic Leukodystrophy compared with nontransplanted control patients. JAMA Neurol. 2016;73:1133\u201340.","journal-title":"JAMA Neurol"},{"key":"1060_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbmt.2018.09.035","volume":"25","author":"A Wadhwa","year":"2019","unstructured":"Wadhwa A, Chen Y, Holmqvist A, Wu J, Ness E, Parman M, et al. Late mortality after allogeneic blood or marrow transplantation for inborn errors of metabolism: a report from the blood or marrow transplant survivor Study-2 (BMTSS-2). Biol Blood Marrow Transplant. 2019;25:328\u201334.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1060_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","volume":"388","author":"M Sessa","year":"2016","unstructured":"Sessa M, Lorioli L, Fumagalli F, Acquati S, Redaelli D, Baldoli C, et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial. Lancet. 2016;388:476\u201387.","journal-title":"Lancet."},{"key":"1060_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10545-017-0052-4","volume":"40","author":"R Penati","year":"2017","unstructured":"Penati R, Fumagalli F, Calbi V, Bernardo ME, Aiuti A. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I. J Inherit Metab Dis. 2017;40:543\u201354.","journal-title":"J Inherit Metab Dis"},{"key":"1060_CR18","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/jnr.23792","volume":"94","author":"JB Rosenberg","year":"2016","unstructured":"Rosenberg JB, Kaminsky SM, Aubourg P, Crystal RG, Sondhi D. Gene therapy for metachromatic leukodystrophy. J Neurosci Res. 2016;94:1169\u201379.","journal-title":"J Neurosci Res"},{"key":"1060_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 2013;341:1233158.","journal-title":"Science."},{"key":"1060_CR20","unstructured":"Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD) (IDEAMLD). 2018 Available at: \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT01510028\n                    \n                  . Accessed 19 Feb 2019."},{"key":"1060_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4324\/9780203413081_chapter_9","volume-title":"Analyzing qualitative data","author":"J Ritchie","year":"1994","unstructured":"Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, editors. Analyzing qualitative data. London: Routledge; 1994. p. 173\u201394."},{"issue":"Suppl 3","key":"1060_CR22","doi-asserted-by":"publisher","first-page":"S257","DOI":"10.1007\/s10545-010-9140-4","volume":"33","author":"O Artigalas","year":"2010","unstructured":"Artigalas O, Lagranha VL, Saraiva-Pereira ML, Burin MG, Lourenco CM, van der Linden H Jr, et al. Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophy. J Inherit Metab Dis. 2010;33(Suppl 3):S257\u201362.","journal-title":"J Inherit Metab Dis"},{"key":"1060_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/0883073809341669","volume":"25","author":"A Mahmood","year":"2010","unstructured":"Mahmood A, Berry J, Wenger DA, Escolar M, Sobeih M, Raymond G, et al. Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature. J Child Neurol. 2010;25:572\u201380.","journal-title":"J Child Neurol"},{"issue":"Suppl 2","key":"1060_CR24","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/bmt.2008.275","volume":"42","author":"A Biffi","year":"2008","unstructured":"Biffi A, Lucchini G, Rovelli A, Sessa M. Metachromatic leukodystrophy: an overview of current and prospective treatments. Bone Marrow Transplant. 2008;42(Suppl 2):S2\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"1060_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0887-8994(00)00164-8","volume":"23","author":"LT Arbour","year":"2000","unstructured":"Arbour LT, Silver K, Hechtman P, Treacy EP, Coulter-Mackie MB. Variable onset of metachromatic leukodystrophy in a Vietnamese family. Pediatr Neurol. 2000;23:173\u20136.","journal-title":"Pediatr Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1060-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1060-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1060-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T19:10:07Z","timestamp":1588014607000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1060-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1060"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1060-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Ethical and Independent Review Services, and informed consent was obtained from all individual participants included in the study. All research performed was in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of the study results was obtained from the parents of the patients. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Magdalena Harrington was an employee of Shire (a Takeda company) when this research was performed, and is now an employee of Pfizer.Diane Whalley, James Twiss, Rebecca Rushton and Susan Martin are employees of RTI Health Solutions.Lynn Huynh and Hongbo Yang are employees of Analysis Group, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"89"}}